Meanwhile, patients with reduced urotensin II levels have increased cardiovascular mortality rates, and urotensin II may provide cardiovascular protection and predict cardiovascular deaths in patients with CKD [50]. The gene discussed is UTS2; the disease is chronic kidney disease.